Abstract:BACKGROUND: Hepatic stellate cells (HSCs) are the key effector cells mediating the occurrence and development of liver fibrosis, while aerobic glycolysis is an important metabolic characteristic of HSC activation. Transforming growth factor-β1 (TGF-β1) induces aerobic glycolysis and is a driving factor for metabolic reprogramming. The occurrence of glycolysis depends on a high glucose uptake level. Glucose transporter 1 (GLUT1) is the most widely distributed glucose transporter in the body and mainly participates in the regulation of carbohydrate metabolism, thus affecting cell proliferation and growth. However, little is known about the relationship between TGF-β1 and GLUT1 in the process of liver fibrosis and the molecular mechanism underlying the promotion of aerobic glycolysis in HSCs.AIM: To investigate the mechanisms of action of GLUT1, TGF-β1 and aerobic glycolysis in the process of HSC activation during liver fibrosis.METHODS: Immunohistochemical staining and immunofluorescence assays were used to examine GLUT1 expression in fibrotic liver tissue. A Seahorse extracellular flux (XF) analyzer was used to examine changes in aerobic glycolytic flux, lactate production levels and glucose consumption levels in HSCs upon TGF-β1 stimulation. The mechanism by which TGF-β1 induces GLUT1 protein expression in HSCs was further explored by inhibiting/promoting the TGF-β1/mothers-against-decapentaplegic-homolog 2/3 (Smad2/3) signaling pathway and inhibiting the p38 and phosphoinositide 3-kinase (PI3K)/AKT signaling pathways. In addition, GLUT1 expression was silenced to observe changes in the growth and proliferation of HSCs. Finally, a GLUT1 inhibitor was used to verify the in vivo effects of GLUT1 on a mouse model of liver fibrosis.RESULTS: GLUT1 protein expression was increased in both mouse and human fibrotic liver tissues. In addition, immunofluorescence staining revealed colocalization of GLUT1 and alpha-smooth muscle actin proteins, indicating that GLUT1 expression was related to the development of liver fibrosis. TGF-β1 caused an increase in aerobic glycolysis in HSCs and induced GLUT1 expression in HSCs by activating the Smad, p38 MAPK and P13K/AKT signaling pathways. The p38 MAPK and Smad pathways synergistically affected the induction of GLUT1 expression. GLUT1 inhibition eliminated the effect of TGF-β1 on HSC proliferation and migration. A GLUT1 inhibitor was administered in a mouse model of liver fibrosis, and GLUT1 inhibition reduced the degree of liver inflammation and liver fibrosis.CONCLUSION: TGF-β1 induces GLUT1 expression in HSCs, a process related to liver fibrosis progression. In vitro experiments revealed that TGF-β1-induced GLUT1 expression might be one of the mechanisms mediating the metabolic reprogramming of HSCs. In addition, in vivo experiments also indicated that the GLUT1 protein promotes the occurrence and development of liver fibrosis.

The Effect of Glucose Transporter 1 on Hexosamine Biosynthesis Pathway in Rat Glomerular Mesangial Cells

Effect of Interaction of Human Mesangial Cells and Endothelial Cells on High Glucose-Induced Expression of TGF-β_1-mRNA and Intervention with Tea Polyphenols

Effects of High Glucose on the Activity of GSH-PX,the Expressions of NOS and ICAM-1 in Human Umbilical Vein Endothelial Cells

Effects of High Glucose, Tea Polyphenols on Mrna Expressions of Connective Tissue Growthfactor, Fibronectin in Human Mesangial Cells

Effects of High Glucose on the Biological Characteristics of Human Gingival Epithelial Cells

Effect of Tea Polyphenols on High Glucose-Induced Expression of GSH-PX and PDGF-B in Human Mesangial Cells

Regulation of the Expression and Function of Glucose Transporter-1 by Tgf-Beta 1 and High Glucose in Mesangial Cells

Inhibition of Glucose Transporter 1 Overexpression in Mesangial Cells by Rhein

Glucose Transporter in Human Glomerular Mesangial Cells Modulated by Transforming Growth Factor Beta and Rhein

Effect of high glucose on rat retinal Müller cells cultured in vitro

Role of Transforming Growth-Factor-Beta in the Growth-Inhibition of Cultured Rat Mesangial Cells in High Glucose Media

Effect of L158,809 and Cilazapril on the Expression of TGF-β1 and Secretion of Extracellular Matrix Proteins in Cultured Human Mesangial Cells

Effect of Rhein on Glucose Transporter-1 Expression and Its Function in Glomerular Mesangial Cells.

The Effect of Simvastatin on the Proliferation of Glomeruli Mesangial Cells and the Secretion of Extracelluar Matrix Proteins under High Concentration of Glucose

Adenosine 5′-triphosphate stimulates the increase of TGF-β1 in rat mesangial cells under high-glucose conditions via reactive oxygen species and ERK1/2

High Glucose-Induced Hypertrophy of Mesangial Cells is Reversed by Connexin43 Overexpression Via PTEN/Akt/mTOR Signaling

High Glucose-induced Fibronectin Upregulation in Cultured Mesangial Cells Involves Caveolin-1-dependent RhoA-GTP Activation Via Src Kinase

Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells

Angiotensin II Type 1 Receptor Activation Mediates High Glucose-Induced Rat Proximal Tubule Epithelial Mesenchymal Transition

Methylglyoxal impairs GLUT4 trafficking and leads to increased glucose uptake in L6 myoblasts

Elevated Transcriptional Co-Activator P102 Mediates Angiotensin II Type 1 Receptor Up-Regulation and Extracellular Matrix Overproduction in the High Glucose-Treated Rat Glomerular Mesangial Cells and Isolated Glomeruli.